MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

On the occasion of this week's board meeting of the Global Immunization Alliance Gavi in Delhi, Médecins Sans Frontières (MSF) calls on its board members to stop supporting the pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) with millions of dollars in funding.

“Pfizer and GSK have reaped more than their fair share of donor money for the pneumococcal vaccine, on top of the combined nearly $50 billion in sales they have made over the last 10 years from the vaccine, so it’s time for Gavi to stop this big pharma payout,” said Kate Elder, Senior Vaccines Policy Advisor, MSF Access Campaign. “Instead of lobbing more money at Pfizer and GSK, Gavi should start supporting countries to prepare for the alternative supplier that promises lower pneumococcal vaccine prices for all countries.”

Pneumonia causes more than a quarter of all deaths in children under the age of five globally – nearly one million young lives lost every year.

Below you will find a press release in English. Please note that interviews can be organized with spokespeople. I stay at your disposal.

Yours sincerely

Djann Jutzeler

Contact us
Djann Jutzeler Communications Officer, Médecins Sans Frontières
Djann Jutzeler Communications Officer, Médecins Sans Frontières
About MSF Switzerland

MSF Switzerland
Médecins Sans Frontières (MSF) is a worldwide movement of current and former field staff, grouped into national and regional associations. Collectively, they make sure that MSF stays true to its mission and principles.

MSF associations

Currently, there are 24 associations. All are independent legal entities, and each elects its own board of directors and president. Most associations have an executive office that raises funds and recruits staff for MSF’s operations.